Cite
HARVARD Citation
Su, P. et al. (n.d.). 513PPreventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer. Annals of oncology. p. . [Online].